Publicaciones RedinRen

• . . ;.

• . . ;.

• The higher diabetogenic risk of tacrolimus depends on pre-existing insulin resistance. A study in obese and lean Zucker rats.

  Rodriguez-Rodriguez AE, Triñanes J, Velazquez-Garcia S, Porrini E, Vega Prieto MJ, Diez Fuentes ML. Am J Transplant. 2013 Jul;13(7):1665-75.

• Renin-angiotensin system blockade and kidney transplantation: a longitudinal cohort study.

  Hernández D, Muriel A, Abraira V, Pérez G, Porrini E, Marrero D. Nephrol Dial Transplant. 2012 Jan;27(1):417-22.

• Is adiponectin a marker of preclinical atherosclerosis in kidney transplantation?

  Cañas L, Bayés B, Granada ML, Ibernon M, Porrini E, Benítez R. Clin Transplant. 2012 Mar-Apr;26(2):259-66.

• Type 1 diabetes increases the expression of proinflammatory cytokines and adhesion molecules in the artery wall of candidate patients for kidney transplantation.

  Triñanes J, Salido E, Fernández J, Rufino M, González-Posada JM, Torres A. Diabetes Care. 2012 Feb;35(2):427-33.

• Early association of low-grade albuminuria and allograft dysfunction predicts renal transplant outcomes.

  Hernández D, Pérez G, Marrero D, Porrini E, Rufino M, González-Posada JM. Transplantation. 2012 Feb 15;93(3):297-303.

• Clinical diagnosis of metabolic syndrome: predicting new-onset diabetes, coronary heart disease, and allograft failure late after kidney transplant.

  Israni AK, Snyder JJ, Skeans MA, Kasiske BL, PORT Investigators. Transpl Int. 2012 Jul;25(7):748-57.

• Primary hyperoxaluria.

  Lorenzo V, Torres A, Salido E. Nefrologia. 2014 May 21;34(3):398-412.

• European Renal Best Practice Guideline on the Management and Evaluation of the Kidney Donor and Recipient.

  Pascual J, Abramowicz D, Cochat P, Claas F, Dudley C, Harden P. Nefrologia. 2014 May 21;34(3):293-301.